Sernova Corp. (TSE:SVA – Free Report) – Equities researchers at Leede Financial upped their FY2027 earnings per share estimates for shares of Sernova in a research report issued on Thursday, September 12th. Leede Financial analyst D. Loe now forecasts that the company will earn ($0.02) per share for the year, up from their prior estimate of ($0.03). Leede Financial currently has a “Speculative Buy” rating and a $1.50 target price on the stock. The consensus estimate for Sernova’s current full-year earnings is ($0.08) per share.
Sernova (TSE:SVA – Get Free Report) last released its quarterly earnings results on Friday, June 14th. The company reported C($0.03) earnings per share for the quarter, hitting analysts’ consensus estimates of C($0.03).
View Our Latest Stock Analysis on Sernova
Sernova Stock Performance
TSE SVA opened at C$0.25 on Monday. The stock has a fifty day simple moving average of C$0.27 and a 200-day simple moving average of C$0.37. Sernova has a twelve month low of C$0.20 and a twelve month high of C$0.83. The company has a current ratio of 0.62, a quick ratio of 18.11 and a debt-to-equity ratio of 16.55. The stock has a market cap of C$79.48 million, a PE ratio of -1.88 and a beta of 1.38.
Insider Buying and Selling at Sernova
In other Sernova news, Director Steven Sangha sold 930,000 shares of the stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of C$0.24, for a total value of C$223,200.00. Insiders have purchased 359,600 shares of company stock valued at $92,771 in the last quarter. Corporate insiders own 12.98% of the company’s stock.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Read More
- Five stocks we like better than Sernova
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Earnings Per Share Calculator: How to Calculate EPS
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- What Are Some of the Best Large-Cap Stocks to Buy?
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.